Cas:5471-46-5 5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one manufacturer & supplier

Chemical Name:5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one

CAS.NO:5471-46-5

Synonyms:3-Hydroxy-5,6-di-p-methoxyphenyl-1,2,4-triazin

Molecular Formula:C₁₇H₁₅N₃O₃

Molecular Weight:309.31900

HS Code:2933699090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:532ºC at 760 mmHg

Density:1.27g/cm3

Index of Refraction:1.621

PSA:77.10000

Exact Mass:309.11100

LogP:2.51610

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Hydroxy-5,6-di-p-methoxyphenyl-1,2,4-triazin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Hydroxy-5,6-di-p-methoxyphenyl-1,2,4-triazin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Hydroxy-5,6-di-p-methoxyphenyl-1,2,4-triazin Use and application,3-Hydroxy-5,6-di-p-methoxyphenyl-1,2,4-triazin technical grade,usp/ep/jp grade.

Related News: Although bird flu poses more of a danger to poultry than humans �� it is not easily transmissible among people �� the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic. 5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one manufacturer A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported. 5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one supplier Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one vendor Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 5,6-bis(4-methoxyphenyl)-2H-1,2,4-triazin-3-one factory Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.